Neurofilaments, particularly NfL, have emerged as promising biomarkers for a wide range of neurological disorders including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD). This evidence concerns the gene NEFL and nervous system disorder.